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Abstract Previous studies have shown that hippocampal
subfields may be differentially affected by Alzheimer’s dis-
ease (AD). This study used an automated analysis technique
and two large cohorts to (1) investigate patterns of subfield
volume loss in mild cognitive impairment (MCI) and AD, (2)
determine the pattern of subfield volume loss due to age,
gender, education, APOE e4 genotype, and neuropsycho-
logical test scores, (3) compare combined subfield volumes to
hippocampal volume alone at discriminating between AD and
healthy controls (HC), and predicting future MCI conversion
to AD at 12 months. 1,069 subjects were selected from the
AddNeuroMed and Alzheimer’s disease neuroimaging ini-
tiative (ADNI) cohorts. Freesurfer was used for automated
segmentation of the hippocampus and hippocampal subfields.
Orthogonal partial least squares to latent structures (OPLS)
was used to train models on AD and HC subjects using one
cohort for training and the other for testing and the combined
cohort was used to predict MCI conversion. MANCOVA and
linear regression analyses showed multiple subfield volumes
including Cornu Ammonis 1 (CA1), subiculum and presu-
biculum were atrophied in AD and MCI and were related to
age, gender, education, APOE e4 genotype, and neuropsy-
chological test scores. For classifying AD from HC, com-
bined subfield volumes achieved comparable classification
accuracy (81.7 %) to total hippocampal (80.7 %), subiculum
(81.2 %) and presubiculum (80.6 %) volume. For predicting
MCI conversion to AD combined subfield volumes and
presubiculum volume were more accurate (81.1 %) than total
hippocampal volume. (76.7 %).
Data used in preparation of this article were obtained from the
Alzheimer’s disease Neuroimaging Initiative (ADNI) database
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Introduction
In recent years, research efforts in Alzheimer’s disease (AD)
have focused upon the discovery of clinically meaningful
and non-invasive biomarkers that can reliably monitor dis-
ease progression and predict future conversion to the dis-
ease. Several groups including our own have proposed the
use of magnetic resonance imaging (MRI) based tools to aid
in the diagnosis of AD (Desikan et al. 2009; Liu et al. 2009)
and predict future conversion from the prodromal stage of
disease often referred to as mild cognitive impairment
(MCI) (McEvoy et al. 2009; Westman et al. 2011a).
Hippocampal atrophy has been frequently observed in
AD (Jack et al. 1992; Fox et al. 1996) and has been
demonstrated in MCI subjects (Devanand et al. 2007), with
increased risk of future conversion to AD in subjects with
smaller hippocampal volumes (Apostolova et al. 2006;
Csernansky et al. 2005). Hippocampal volumetry has been
a useful marker of AD pathology but seems to be insuffi-
ciently sensitive for distinguishing between MCI subjects
bearing a high risk of AD conversion from those who
remain clinically stable (Mueller et al. 2010). Post-mortem
studies have also demonstrated that hippocampal atrophy
in AD is non-uniform, with Cornu Ammonis 1 (CA1) and
subicular atrophy reported in early AD (Braak and Braak
1991; West et al. 2004).
So far, only a few studies have attempted to measure
regional atrophic changes within the hippocampus using
manual delineation and 3D surface mapping (Mueller and
Weiner 2009; Apostolova et al. 2010; Costafreda et al.
2011). Manual delineation of the subfield boundaries is
both a time consuming and labour intensive process which
limits its widespread applicability in practice. However,
recent developments in image acquisition have made it
possible to segment the hippocampus into its subfields in a
fully automated fashion and this method has now been
validated using ultra high resolution MRI (Van Leemput
et al. 2009). A recent small study applied this technique to
15 MCI subjects using conventional 3D T1 weighted vol-
ume imaging and demonstrated that segmenting subfields
increased sensitivity in diagnosing MCI (Hanseeuw et al.
2011). The current study uses an extensive dataset created
by combining two large cohorts from the AddNeuroMed
and the Alzheimer Disease Neuroimaging Initiative
(ADNI) studies to build on and extend this earlier work.
In this study we aimed to (1) investigate the differences
in hippocampal subfields between subject groups at base-
line in a cohort of 1,069 subjects, (2) determine patterns of
subfield volume loss in relation to age, gender, education,
APOE e4 genotype, and neuropsychological tests from
mini mental state exam (MMSE) and Alzheimer disease
Assessment Score-1 (ADAS-1) scores, and (3) compare
combined subfield volumes using orthogonal partial least
squares (OPLS) multivariate analysis to hippocampal vol-
ume alone for discriminating between AD and healthy
control (HC) subjects and predicting future conversion
from MCI to AD at 12 months.
Materials and Methods
Study Data and Inclusion and Diagnostic Criteria
The data used in this study were derived from two large
multicentre cohorts, the AddNeuroMed and ADNI cohorts.
The AddNeuroMed study is an integrated project funded by
the European Union Sixth Framework Program and aims to
establish and validate novel biomarkers of disease and
treatment based upon in vitro and in vivo human and ani-
mal models of AD. Data was collected from six partici-
pating sites across Europe: University of Kuopio, Finland;
University of Perugia, Italy; Aristotle University of Thes-
saloniki, Greece; King’s College London, United King-
dom; University of Lodz, Poland; and University of
Toulouse, France (Lovestone et al. 2009; Simmons et al.
2009, 2011).
Data from the ADNI study was downloaded from the
ADNI at the LONI website (www.loni.ucla.edu/ADNI, PI
Michael M. Weiner). The initiative was launched in 2003
by the National Institute on Ageing, the National Institute
of Biomedical Imaging and Bioengineering, the Food and
Drug Administration, private pharmaceutical companies
and non-profit organisations, as a 5 years public–private
partnership. The primary goal of ADNI has been to test
whether MRI, positron emission tomography (PET), and
other biological markers are useful in clinical trials of MCI
and early AD. Subjects aged 55–90 from over 50 sites
across the U.S and Canada participated in the research, and
imaging, clinical, and biological samples were collected at
multiple time points (Jack et al. 2008). A detailed
description of the inclusion criteria for the study can be
found on its webpage (http://www.adni-info.org/scientists/
aboutADNI.aspx#).
A total of 1,069 subjects were included in this study
(AD = 291, MCI = 447, HC = 331). The demographics
of the cohorts are given in Table 1. Of the 447 MCI sub-
jects in our whole cohort, 90 converted to an AD diagnosis
(MCI converters) at 12 months.
For the AddNeuroMed cohort, subjects were patients
who attended local memory clinics and received a diag-
nosis of MCI while HC subjects were recruited from non-
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related members of the patient’s families, caregiver rela-
tives, and social centres for the elderly or General Practi-
tioner (GP) surgeries. Informed consent was obtained for
all subjects and the study was approved by the ethical
review boards of each participating country. The general
inclusion and exclusion criteria were as follows.
AD
(1) diagnosis established by National Institute of Neuro-
logical and Communicative Disorders and Stroke and the
Alzheimer’s Disease and Related Disorders Association
(NINCDS-ADRDA) and Diagnostic and Statistical Manual
of Mental Disorders IV (DSM IV) criteria, (2) MMSE
score ranged from 12 to 28. Subjects were excluded from
the study if any psychiatric or neurological illness other
than AD was present, and if subjects presented with a
systemic illness or signs of organ failure.
MCI
(1) subjects had MMSE scores between 24 and 30, (2)
subjective memory complaint with preserved activities of
daily living, (3) Clinical Dementia Rating (CDR) score of
0.5, (4) Geriatric depression scale score less than or equal
to 5, (5) absence of dementia in accordance with NINCDS-
ARDA criteria. A 12 months follow up was used to
determine whether MCI subjects converted to AD (MCI
converters) or remained clinically stable (stable MCI).
HC
(1) MMSE scores between 24 and 30, (2) CDR score of 0,
(3) no presence of neurological or psychiatric illness, and
non-demented.
MMSE, CDR, and the Consortium to Establish a Reg-
istry for Alzheimer’s Disease (CERAD) cognitive battery
were assessed for each subject. The CERAD cognitive
battery was replaced with the Alzheimer’s disease assess-
ment scale for AD subjects in AddNeuroMed. The CERAD
battery employs the same 10 word recall task as the Alz-
heimer’s assessment scale, only the scoring is inverted.
Therefore, the mean number of words not recalled in the
CERAD word list task was calculated in order to obtain
comparable measures of memory for all diagnostic groups.
This revised cognitive parameter was named ADAS-1
corresponding to the first subtest of the Alzheimer’s disease
assessment scale.
MRI Acquisition
Standardized MRI data acquisition techniques were in
place for AddNeuroMed and ADNI to ensure homogeneity
across data acquisition sites. A detailed description of the
ADNI data acquisition protocol can be found at www.loni.
ucla.edu/ADNI/research/Cores/index.shtml. The imaging
protocol included a 1.5T high resolution T1 weighted
sagittal 3D MP-RAGE volumes (voxel size
1.1 9 1.1 9 1.2 mm3), and axial proton density with T2
weighted fast spin echo images. A comprehensive quality
control procedure was carried out on all MR images
according to the AddNeuroMed quality control framework
(Simmons et al. 2009, 2011).
Hippocampal Subfield Segmentation
Image analysis was carried out using the Freesurfer image
analysis pipeline (version 5.1.0). These procedures have
been described in detail in previous publications (Dale
et al. 1999; Fischl et al. 2002; Se´gonne et al. 2004; Fischl
Table 1 Demographic, clinical and neuropsychological data in AD, MCI converters, stable MCI, and control subjects
AD (n = 291) MCI converters (n = 90) Stable MCI (n = 357) HC (n = 331) p*
Gender (male/female) 131/160a 54/36 216/141b 166/165 0.001
Age 75.4 ± 7.0 74.1 ± 6.6 75.1 ± 7.0 75.0 ± 5.7 0.439
Years of education 12.1 ± 4.7a,b,c 14.0 ± 4.1 14.3 ± 4.4 14.3 ± 4.4 \0.001
MMSE 22.4 ± 3.4a,b,c 26.5 ± 1.8b 27.1 ± 1.7b 29.1 ± 1.1 \0.001
ADAS-1 6.3 ± 1.5a,b,c 5.3 ± 1.3a,b 4.6 ± 1.4b,c 3.1 ± 1.3 \0.001
CDR 0.9 ± 0.4a,b,c 0.5b 0.5b 0 \0.001
APOE e4 genotype (?ive/-ive) 183/108 57/33 171/186 93/238 \0.001
Data are represented as mean ± and standard deviation. Chi square was used for gender and APOE e4 genotype comparison. ANOVA with
Bonferroni post hoc test was used for age, education, and neuropsychological scores
a Significant compared to stable MCI
b Significant compared to healthy controls (HC)
c Significant compared to MCI converters
* p values corrected for multiple comparisons using the Bonferroni method
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et al. 2004). Initially volumetric segmentation involved the
removal of non-brain tissue using a hybrid watershed/sur-
face deformation procedure (Se´gonne et al. 2004), auto-
mated Talairach transformation, segmentation of the
subcortical white matter and deep grey matter volumetric
structures (Fischl et al. 2004).
Automated segmentation of the hippocampus was per-
formed to define anatomical subfield labels using a
Bayesian modelling approach and a computational model
of the areas surrounding the hippocampus. An atlas mesh
had previously been built and validated from manual
delineations in ultra-high resolution MRI scans of 10
individuals (Van Leemput et al. 2009). These delineations
include the fimbria, presubiculum, subiculum, CA1, CA2/
3, and CA4-DG subfields as well as the hippocampal fis-
sure. Figure 1 illustrates the delineations made to define the
different subfields of the hippocampus. For more details
about this technique and the borders used to define the
different subfields, see Van Leemput et al. (2009).
All subfield measures were normalised by the subject’s
intracranial volume derived from Freesurfer using the fol-
lowing formula: volumenorm = volumeraw 9 1,000/ICV in
cm3 (Westman et al. 2013). This automated segmentation
approach has been recently applied to a small group of
MCI subjects (Hanseeuw et al. 2011).
Statistical Analysis
Statistical analysis was conducted using PASW Statistics
(Version 17. 0; SPSS inc., USA). Categorical variables
were inspected using the Chi square test while continuous
variables were tested using ANOVA with Bonferroni post
hoc comparisons. Hippocampal subfield volumes were first
analysed using MANCOVA utilising Bonferroni correction
by adopting a general linear model procedure, adjusting for
age, gender, education, and APOE e4 genotype as covari-
ates. Bonferroni pairwise comparisons were performed to
inspect subfield volume differences between the groups.
Multiple regression analyses were conducted in R ver-
sion 2.15.2 using the lm function from the R stats package
and Bonferroni correction for multiple comparisons. Pat-
terns of subfield volume loss were tested in relation to the
effects of age, gender, education, APOE e4 genotype, and
neuropsychological test scores from MMSE and ADAS-1.
In this step, all subfield measures were tested as dependent
variables by disease group (AD, MCI converters, stable
MCI, and HC) as a whole. Age, gender, years of education,
APOE e4 genotype, and neuropsychological scores from
MMSE and ADAS-1 tests was treated as independent
variables for identifying subfield specific effects. 10 fold
cross validation was performed by fitting linear regression
models to the data, excluding 1/10th of the data in each
fold and using the fitted model for prediction on data that
was excluded from the fold.
Hippocampal subfields were subsequently analysed
using Orthogonal Partial Least Squares (OPLS) (Wiklund
et al. 2008; Trygg and Wold 2002), a supervised multi-
variate data analysis method included in the software
package SIMCA (Umetrics AB, Umea, Sweden). Al1 14
variables (left and right subfields) were used for OPLS
analysis. Classification models were created for distin-
guishing between AD and HC subjects at baseline. The AD
versus HC models were subsequently treated as classifiers
to investigate how well the hippocampal subfields could
predict future MCI conversion to AD at 12 months follow
up. Seven-fold cross validation was used for all models.
Using this approach we created 4 OPLS models; 2 for the
total hippocampus and 2 for the combination of subfield
volumes. The first model for each region comprised the
AddNeuroMed cohort and the second model comprised the
ADNI cohort. To further validate the models created the
AddNeuroMed cohort was used as the training set and the
ADNI cohort as a test set (and vice versa) to see how well
the models could predict new and unseen data. The com-
bined ADNI and AddNeuroMed cohort from the AD versus
HC comparison was used as a classifier to investigate the
reliability of predicting MCI conversion to AD at
Fig. 1 a Coronal and b sagittal views of the hippocampus
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12 months. This OPLS classification approach has been
extensively validated (Bylesjo et al. 2006; Wiklund et al.
2008; Westman et al. 2011c) and applied to several bio-
marker discovery studies in AD (Mangialasche et al. 2010;
Westman et al. 2011a, 2012; Spulber et al. 2013).
Sensitivity and specificity were calculated from the
cross-validated prediction values of the OPLS models. The
positive and negative likelihood ratios (LR? = sensitivity/
(100-specificity) and LR- = (100-sensitivity)/specific-
ity)) were determined. A positive likelihood ratio between
5 and 10 or a negative likelihood ratio between 0.1 and 0.2
increases the diagnostic value in a moderate way, while a
value above 10 or below 0.1 significantly increases the
diagnostic value of the test.
Receiver operating characteristic (ROC) curves were
calculated for the individual subfield volume models
using the ROCR library (version 2.1) in R. ROC curves
provide a graphical means to interpret the quality of
separation and are created by plotting the true positive
rate (sensitivity) versus the false positive rate (1-speci-
ficity) for various thresholds. The discriminant value of
the corresponding ROC curve can be obtained by calcu-
lating the area under the curve (AUC). AUC values range
from 0.5 (random discriminations no better than chance)
to 1.0 (perfect discrimination). The pROC (Receiver
Operating Characteristic) package (version 1.5.4) (Robin
et al. 2011) in R was used to perform area under the
curve (AUC) statistical comparisons between the com-
bined subfield and total hippocampal volume models in
the AD vs. HC and MCI converter vs MCI non-converter
models.
Results
Demographics, Neuropsychological, and Global
Clinical Measurements
1,069 subjects were included in the current study
(AD = 291, MCI = 447, HC = 331) from the AddNeur-
oMed and ADNI cohorts. Results from global, clinical and
cognitive assessments revealed that scores on MMSE,
CDR, and ADAS-1 were poorest amongst AD and best
amongst control subjects as expected (Table 1).
Hippocampal Subfields
Hippocampal subfield volumes from the left and the right
hemisphere were used to determine the pattern of subfield
atrophy in AD, MCI-converter, MCI stable and HC sub-
jects. Comparisons of the bilateral CA1, CA2-3, CA4-DG,
subiculum, and presubiculum were significant across all
groups (\0.0001) after correction for multiple comparisons
and demonstrated similar results in pairwise comparisons
(Table 2 and Fig. 2). No significant volume differences
were found for the left and right hippocampal fissure
between these groups.
Table 2 Hippocampal subfield differences in AD, MCI converters, stable MCI, and healthy control subjects
AD (n = 291) MCI converters (n- = 90) Stable MCI (n = 357) HC (n = 331) p
Left presubiculum 309.2 ± 63.5a,b 323.7 ± 64.6a,b 363.2 ± 70.9b,c 409.5 ± 62.963.1 \0.0001
Left subiculum 449.0 ± 86.7a,b 465.9 ± 84.1a,b 520.9 ± 91.0b,c 579.5 ± 76.2 \0.0001
Right presubiculum 307.9 ± 64.0a,b 318.7 ± 63.5a,b 359.2 ± 70.8b,c 399.0 ± 64.3 \0.0001
Right subiculum 449.9 ± 90.4a,b 467.1 ± 92.7a,b 523.5 ± 96.4b,c 575.5 ± 77.5 \0.0001
Left CA4-DG 399.2 ± 73.5a,b 416.2 ± 67.6a,b 453.1 ± 79.0b,c 494.2 ± 67.7 \0.0001
Left CA2-3 716.4 ± 134.2a,b 747.6 ± 127.1a,b 804.6 ± 139.8b,c 877.9 ± 121.0 \0.0001
Right CA4-DG 418.3 ± 78.0a,b 436.1 ± 80.6a,b 476.9 ± 83.2b,c 511.6 ± 69.8 \0.0001
Right CA2-3 765.4 ± 143.4a,b 793.5 ± 146.4a,b 858.8 ± 146.0b,c 920.7 ± 127.7 \0.0001
Left fimbria 29.9 ± 21.5a,b 33.6 ± 25.6b 37.9 ± 23.3b 49.1 ± 23.1 \0.0001
Left CA1 286.8 ± 55.5a,b 298.2 ± 49.1b 308.1 ± 50.1b 322.4 ± 45.0 \0.0001
Right CA1 293.8 ± 57.0a,b 301.5 ± 53.2b 315.7 ± 54.2b,c 328.5 ± 45.8 \0.0001
Right fimbria 26.9 ± 18.8a,b 31.8 ± 21.5b 32.3 ± 18.8b 41.5 ± 19.9 \0.0001
Right hippocampal fissure 44.8 ± 26.2 46.2 ± 23.8 45.1 ± 23.8 47.7 ± 24.1 2.144
Left hippocampal fissure 39.8 ± 22.7 37.6 ± 22.8 40.7 ± 21.6 41.4 ± 21.1 3.276
Absolute Hippocampal subfields are presented (mm3). However, normalised hippocampal subfields (absolute hippocampal subfield/intracranial
volume) were used in MANCOVA with Bonferroni pairwise comparisons. Age, gender, education, and APOE e4 genotype were used as
covariates. p values were corrected for multiple comparisons using the Bonferroni method
a Significant compared to stable MCI
b Significant compared to healthy controls (HC)
c Significant compared to MCI converters
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In the left hippocampus, presubiculum (F = 144.5,
p\ 0.0001) and subiculum (F = 144.3, p\ 0.0001) vol-
umes were most significantly reduced in AD, MCI converter
and MCI stable subjects compared to healthy controls. The
same pattern of subfield atrophy was also observed in the
right hippocampus for these groups for both presubiculum
(F = 122.1, p\ 0.0001) and subiculum (F = 120.0,
p\ 0.0001) relative to healthy controls. MCI-converters
displayed significant subfield volume losses in the bilateral
subiculum (right = p\ 0.0001, left = p\ 0.0001),
subiculum (right = p\ 0.0001, left = p\ 0.0001), CA4-
DG (right = p\ 0.0001, left = p\ 0.0001), and CA2-3
(right = p\ 0.0001, left = p\ 0.0001) relative to stable
MCI subjects. However, no significant differences in any of
the subfield volume measures were observed between AD
and MCI-converter subjects.
Relationship Between Neuropsychological Test Scores
and Hippocampal Subfields
A significant positive effect for MMSE was found in
relation to all hippocampal subfield volumes except
bilateral hippocampal fissure, indicating that subjects with
lower MMSE scores had reduced subfield volumes
(Table 3). On the other hand, a significant negative effect
was observed for ADAS-1 scores across all subfield
volumes except the bilateral hippocampal fissure, indi-
cating that subjects with higher ADAS-1 scores (mean
number of words not recalled) had lower subfield volumes
(Table 3).
Relationship Between Age, Education, APOE e4
Genotype, and Hippocampal Subfields
A significant negative effect of age was observed in rela-
tion to all subfield volumes indicating that older subjects
had lower hippocampal subfield volumes. In particular, the
strongest effects of age were found in the right presubic-
ulum (b = -0.32, p\ 0.001), and left presubiculum areas,
the right fimbria (b = -0.31, p\ 0.001), and the right
subiculum and left subiculum areas (b = -0.28,
p\ 0.001).
Linear regression models were also created to test for
the effect of gender on subfield volume differences in the
male (n = 567) and female (n = 502) subjects. A signifi-
cant positive effect of gender was found in the right fimbria
and left fimbria areas, and in the right and left CA4-DG
subfield volumes (Table 4).
A significant negative effect of education was only

























Fig. 2 Bar plot of subfield volumes of AD (n = 291), MCI
converters (n = 90), MCI stable (n = 357), and healthy control
(HC) subjects (n = 331). Error bars represent SEM = SD/Hn.
Subfield volumes are represented in mm3. R = subfield volumes
from the right hemisphere, L = subfield volumes from the left
hemisphere
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The analysis was repeated for subjects that were carriers
and non-carriers of the APOE e4 allele. APOE E4 genotype
was negatively related to all subfield volumes suggesting
that subjects with an APOE E4 allele had smaller subfield
volumes (Table 5).
AD and HC Classification for the Combined
AddNeuroMed and ADNI Cohort
For the joint AddNeuroMed and ADNI AD versus HC
model, combining the subfield volumes resulted in an
accuracy of 81.7 % (sensitivity = 80.4 %, specific-
ity = 82.8 %, AUC = 0.895) compared to 80.7 % for total
hippocampal volume (sensitivity = 79.2 %, specific-
ity = 82.8 %, AUC = 0.887) (Table 6). These result were
statistically significantly different in terms of the observed
AUC differences between the two models (AUC differ-
ence = 0.008, p = 0.001).
Combining subfield volumes resulted in similar classifi-
cation accuracy to the subiculum (accuracy = 81.2 %, sen-
sitivity = 83.5 %, specificity = 79.2 %, AUC = 0.887) and
presubiculum alone (accuracy = 80.6 %, sensitiv-
ity = 83.2 %, specificity = 78.3 %, AUC = 0.882), but
higher accuracies than the other individual subfield volume
measures (Table 7). Figure 3 illustrates ROC curves for the
corresponding individual subfield volumes for distinguishing
AD and HC subjects.
Model Validation for AD and HC Classification
Seven fold cross validation was used to determine the
robustness of all the models. In this study models were
validated using an external test set. The ADNI model was
used as a training set and predictions were made using the
AddNeuroMed cohort as the external test set and vice
versa. The results are similar to those obtained by cross
validation (Table 6). For the combination of hippocampal
subfields, using the AddNeuroMed cohort as the test set
and the ADNI cohort as the training set resulted in a similar
classification accuracy, 82.1 % (sensitivity = 77.1 %,
specificity = 86.9 %, AUC = 0.90) compared to 81.1 %
for total hippocampal volume (sensitivity = 75.2 %,
specificity = 86.9 %, AUC = 0.897). Similar results for
the combination of hippocampal subfields and total hip-
pocampal volume were obtained when using the ADNI
cohort as the test set and the AddNeuroMed cohort as the
training set (Table 5). For further validation, we compared
if subjects were classified differently between the different
models for the combination of hippocampal subfields (for
Table 3 MMSE and ADAS-1 effect on hippocampal subfield vol-
umes in the combined cohort
MMSE score ADAS-1 score
Hippocampus b t p* b t p*
Left CA1 0.24 8.41 \0.001 -0.19 -6.68 \0.001
Right CA1 0.23 8.15 \0.001 -0.16 -5.47 \0.001
Left CA2-3 0.34 12.29 \0.001 -0.34 -11.93 \0.001
Right CA2-3 0.35 12.40 \0.001 -0.28 -9.67 \0.001
Left CA4-DG 0.37 13.47 \0.001 -0.36 -12.51 \0.001
Right CA4-DG 0.37 13.31 \0.001 -0.31 -10.65 \0.001
Left Fimbria 0.23 8.08 \0.001 -0.23 -8.07 \0.001
Right Fimbria 0.19 6.51 \0.001 -0.18 -6.19 \0.001
Left Presubiculum 0.43 15.51 \0.001 -0.42 -15.19 \0.001
Right Presubiculum 0.40 14.11 \0.001 -0.39 -13.60 \0.001
Left Subiculum 0.43 15.57 \0.001 -0.42 -15.06 \0.001
Right Subiculum 0.40 14.49 \0.001 -0.36 -12.67 \0.001
Age, gender, education and APOE e4 genotype were introduced as covariates
in these models
* p values from the regression models were corrected for multiple comparisons
using the Bonferroni method
Table 4 Age and Gender effect
on hippocampal subfields in the
combined cohort
a Gender, years of education,
and APOE E4 genotype were
used as covariates
b Subject age, years of
education, and APOE E4
genotype were used as
covariates
* p values from each regression
model were corrected for
multiple comparisons using the
Bonferroni method
Hippocampus Agea Genderb
b t PRESS p value* b t PRESS p value*
Left CA1 -0.1 -3.31 42.8 0.012 0.04 1.16 0.239 2.964
Right CA1 -0.09 -3.01 42.7 0.036 0.04 1.3 0.239 2.304
Left CA2-3 -0.24 -7.75 41.0 \0.001 0.09 2.93 0.237 0.036
Right CA2-3 -0.23 -7.62 40.8 \0.001 0.1 3.2 0.237 0.012
Left CA4-DG -0.24 -7.92 40.6 \0.001 0.1 3.19 0.237 0.012
Right CA4-DG -0.25 -8.2 40.7 \0.001 0.12 3.74 0.236 \0.001
Left Fimbria -0.25 -8.42 39.6 \0.001 0.12 3.74 0.236 \0.001
Right Fimbria -0.29 -9.72 40.5 \0.001 0.13 4.24 0.235 \0.001
Left Presubiculum -0.31 -10.28 40.0 \0.001 0.09 2.71 0.238 0.084
Right Presubiculum -0.32 -10.91 40.1 \0.001 0.09 2.89 0.237 0.048
Left Subiculum -0.28 -9.09 38.9 \0.001 0.12 3.85 0.236 0.012
Right Subiculum -0.28 -9.25 39.3 \0.001 0.12 3.38 0.236 0.012
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example classified as AD in one model and HC in another
model). We compared the single cohort cross validated
models with the combined cohort model and the single
cohort models using the train/test approach. The results
demonstrate that classification agreement for the different
comparisons were high, lying between 89.5–98.8 %
(Table 8).
Predicting MCI Conversion
Models previously constructed using AD and HC subjects
from the combined cohort were applied to our large
external test set of MCI subjects (n = 447) to predict
future conversion to AD. These classifiers subsequently
identified MCI subjects with an AD like brain structure
(percentage classified as AD-like) or a healthy control-like
brain structure (percentage classified as HC-like). During
the 12 month follow up interval, 90 MCI subjects from the
AddNeuroMed and ADNI cohorts met the clinical criteria
for AD, and 357 MCI subjects remained clinically stable.
The combined subfield volumes classifier correctly
identified 81.1 % of MCI converters from baseline images,
with the presubiculum also correctly identifying 81.1 % of
MCI-c with an AD-like pattern of subfield atrophy. In
comparison, total hippocampal volume identified 76.7 % of
MCI-c correctly. The predictive accuracies from the clas-
sifiers ranged between 56.7–81.1 % for MCI-c predictions
(Table 9).
However, a considerable number of MCI-s subjects
were also predicted with an AD-like pattern of atrophy
despite their clinically stable condition at 12 months follow
up. For instance, the combined subfield volumes classifier,
which was the most robust for MCI-c prediction, identified
only 48.7 % of MCI-s with a HC-like subfield structure. A
similar result was observed for the total hippocampal vol-
ume classifier which only identified 50.1 % of MCI-s
correctly. Mean OPLS scores from the combined subfield
volumes classifier and total hippocampal volume classifier
were 0.50 ± 028 and 0.49 ± 0.27 (mean ± standard
deviation) respectively (Fig. 4). As a result, differences in
OPLS scores between the two classifiers were not statisti-
cally significant (Wilcoxon signed rank sum test, Z =
-0.725, p = 0.469) despite the difference in AD-like
MCI-c predictions. HC-like predictive accuracies in MCI-s
Table 5 Years of education
and APOE genotype effect on
hippocampal subfields in the
combined cohort
a Subject age, gender, and
APOE E4 genotype were used
as covariates
b  Subject age, gender and
years of education were used as
covariates
* p values from each regression
model were corrected for
multiple comparisons using the
Bonferroni method
Years of educationa APOE E4 genotypeb
b t p* b t p*
Left CA1 -0.59 -1.92 0.66 0.22 -7.29 0.012
Right CA1 -0.95 -3.11 0.024 0.17 -5.74 0.012
Left CA2-3 -0.004 -0.14 10.668 0.24 -7.89 \0.001
Right CA2-3 -0.01 -0.45 7.86 0.26 -8.46 \0.001
Left CA4-DG -0.002 -0.06 11.46 0.253 -8.31 \0.001
Right CA4-DG -0.009 -0.27 9.408 0.27 -8.8 \0.001
Left Fimbria 0.028 0.88 4.548 0.1 -3.05 0.024
Right Fimbria 0.08 2.39 0.204 0.07 -2.28 0.276
Left Presubiculum 0.03 0.81 5.004 0.24 -7.8 \0.001
Right Presubiculum 0.05 1.57 1.404 0.23 -7.28 \0.001
Left Subiculum 0.03 1.06 3.48 0.27 -8.84 \0.001
Right Subiculum 0.02 0.65 6.216 0.27 -8.66 \0.001
Table 6 Comparison of performance for the different cohort models in the AD vs. HC classification
Total Hippocampus Hippocampal subfields
ACC (%) SENS (%) SPE (%) AUC Q2 (Y) ACC (%) SENS (%) SPE (%) AUC Q2 (Y)
AddNeuroMed (cv) 80.7 (74.8–85.4) 76.2 (67.2–83.3) 85.1 (77.1–90.6) 0.897 0.439 80.2 (74.3–85.0) 78.1 (69.3–84.9) 82.2 (73.9–88.3) 0.90 0.441
ADNI (cv) 81.5 (77.4–84.9) 81.2 (75.0–86.2) 81.7 (76.1–86.2) 0.884 0.404 82.0 (77.9–85.6) 81.2 (75.0–86.2) 82.6 (77.1–87.0) 0.892 0.433
Combined (cv)* 80.7 (77.4–83.6) 79.2 (74.1–83.5) 82.8 (78.3–86.5) 0.887 – 81.7 (78.4–84.5) 80.4 (75.5–84.6) 82.8 (78.3–86.5) 0.895 –
AddNeuroMeda 81.1 (75.3–85.8) 75.2 (66.2–82.5) 86.9 (79.2–92.0) 0.897 – 82.1 (76.4–86.7) 77.1 (68.2–84.1) 86.9 (79.2–92.0) 0.90 –
ADNIb 80.2 (76.1–83.8) 84.4 (78.5–88.9) 76.8 (70.8–81.8) 0.884 – 80.7 (76.6–84.3) 88.2 (82.7–92.1) 74.6 (68.5–79.8) 0.881 –
a AddNeuroMed dataset used as the test set and ADNI data as the training set
b ADNI data used as the test set and AddNeuroMed dataset as the training set
* AddNeuroMed and ADNI cohorts used as the combined cohort model, confidence intervals presented within parenthesis
CV cross validation, AUC area under the curve
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predictions only ranged between 46.8–51.8 % which is
because many of these MCI-s subjects will convert to AD
at a future stage and already demonstrate an Alzheimer like
pattern of hippocampal subfield atrophy.
Discussion
Using an automated image analysis pipeline to explore the
subfields of the hippocampus, we found that AD and MCI
converters displayed a widespread pattern of subfield
atrophy, including the bilateral subiculum, presubiculum
and CA1 which have been reported in previous studies.
Using the same image analysis approach, Hanseeuw et al.
(2011) previously reported significant volume losses in the
subiculum and CA2-3 region of the hippocampus in a small
group of 15 amnestic MCI subjects and 15 healthy controls.
We have extended this preliminary work to data from two
large studies which together contain a more heterogeneous
group of AD and MCI subjects that more accurately reflect
the population of MCI and AD. The pattern of hippocampal
volume loss that was found was wider than previous reports
which have used either manual delineation techniques
hippocampal subfield segmentation (Mueller and Weiner
2009; Mueller et al. 2010), 3D surface mapping (Apos-
tolova et al. 2010) or shape analysis techniques (Csernan-
sky et al. 2005; Costafreda et al. 2011) A similar pattern of
subfield atrophy was observed for AD subjects and MCI
converters suggesting that MCI converters may represent
an imaging profile more similar to AD subjects than stable
MCI. The pattern of hippocampal subfield loss, though
wider than previously reported is in agreement with pre-
vious neuropathological studies reporting early neuronal
loss in the subiculum, CA4-DG, and CA1 (West et al.
2004). Larger datasets are more likely to contain subjects
with different types of atrophy which could explain the
widespread pattern of subfield volume losses reported in
the present study.
Table 7 Comparison of performance for OPLS AD vs. HC classification models
ACC (%) SEN (%) SPE (%) AUC PPV (%) NPV (%) LR? LR-
CA1 66.0 (62.2–69.6) 68.0 (62.5–73.1) 65.9 (60.6–70.8) 0.749 63.7 70.1 1.99 (1.68–2.36) 0.49 (0.40–0.58)
CA2-3 75.4 (71.9–78.6) 77.0 (71.8–81.4) 74.0 (69.0–78.5) 0.843 72.3 78.5 2.96 (2.44–3.59) 0.31 (0.25–0.39)
CA4-DG 76.9 (73.4–80.0) 79.7 (74.7–83.9) 74.3 (69.4–78.7) 0.853 73.2 80.7 3.11 (2.56–3.76) 0.27 (0.22–0.35)
Fimbria 68.2 (64.4–71.7) 69.8 (64.3–74.8) 66.8 (61.5–71.6) 0.745 64.9 71.5 2.10 (1.77–2.49) 0.45 (0.37–0.55)
Presubiculum 80.6 (74.9–83.4) 83.2 (78.4–87.0) 78.3 (73.5–82.4) 0.882 77.1 84.1 3.08 (3.10–4.72) 0.22 (0.17–0.28)
Subiculum 81.2 (77.9–84.1) 83.5 (78.8–87.3) 79.2 (74.5–83.2) 0.887 77.9 84.5 4.01 (3.23–4.97) 0.21 (0.16–0.27)
Confidence intervals are presented within parenthesis. AUC area under the curve, PPV positive predictive value, NPV negative predictive value,
LR? positive likelihood ratio, LR- negative likelihood ratio
Fig. 3 a ROC curve for AD versus HC classification using individual
subfield measures, b ROC curve for MCI-c and MCI-s classification
using individual subfield measures. The curve is calculated with a
95 % probability assurance. ROC receiver operating characteristic,
AD Alzheimer’s disease, HC healthy control, MCI-c MCI-converter,
MCI-s stable MCI
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Relationship Between Neuropsychological Test Scores
and Hippocampal Subfields
A significant positive effect for both MMSE and ADAS-1
was found in relation to all hippocampal subfield volumes,
indicating that subjects with lower MMSE scores and
higher ADAS-1 scores had lower subfield volumes. This
confirms the relationship between diffuse hippocampal
volume loss and poorer neuropsychological test scores
(Scheltens et al. 1992; Liu et al. 2009).
Relationship Between Age, Gender, Education, APOE
e4 Genotype, and Hippocampal Subfields
Previous studies investigating the influence of age on
hippocampal subfields have found significant negative
effects associated with CA1 and CA2-3 subfield volumes
(Mueller and Weiner 2009). Consistent with this previous
work, using a larger dataset we also found a significant
negative effect of age but in relation to all subfield vol-
umes. However, years of education was only significantly
associated with the right CA1 and right fimbria. Gender
specific differences in the pattern of subfield volume loss
were found, with female subjects demonstrating lower
bilateral CA2-3, CA4-DG, fimbria, presubiculum and
subiculum volumes. Previous work with AD patients sug-
gests that gender specific differences in the rate of hippo-
campal volume loss are not entirely clear. For example, a
previous study has reported a higher prevalence and inci-
dence of AD in females (Barnes et al. 2005), whereas sex
hormone differences have been suggested as an explana-
tion of any gender divergence (Gouras et al. 2000). On the
other hand, our findings suggest that carriers of the e4 allele
had smaller subfield volumes. which is in agreement with
previous studies that have demonstrated a strong neuro-
anatomic effect of APOE e4 genotype on the entire hip-
pocampal region. (Jack et al. 1998; Reiman et al. 1998).
AD and HC Classification
In this study we used the multivariate OPLS technique to
distinguish between AD and control subjects. This method
has previously been used for distinguishing between AD
and control subjects (Westman et al. 2011a, b, c, d), as well
as predicting conversion from MCI to AD using MRI
regional measures and a combination of MRI regional
measures and magnetic resonance spectroscopy (MRS)
measures (Westman et al. 2010, 2011a, b, c, d). Hippo-
campal subfields have not been studied using this approach
but several other studies have used alternative multivariate
techniques including support vector machines, principal
components analysis, and partial least squares to latent
structures and linear discriminant analysis to analyse
multiple MRI regional measures (Fan et al. 2008; McEvoy
et al. 2009; Klo¨ppel et al. 2008; Vemuri et al. 2008; Plant
et al. 2010).
Studies that have attempted to distinguish between AD
and control subjects have often done so using medial
temporal structures such as the hippocampus and entorhi-
nal cortex and reported accuracies of 80–90 % (Fox et al.
1996; Jack et al. 1992). Although prior studies have
reported accuracies of up to 100 % in discriminating
between AD and control subjects(Fan et al. 2008; Lerch
et al. 2008), some studies used smaller samples, included
more severely impaired AD patients or failed to cross-
validate their findings. Here, using two large multicentre
studies we segmented the hippocampus into its different













Total n 212 410 212 410
Same classification (n) 197 405 196 367
Same classification (%) 92.9 98.8 92.5 89.5
Different classification (n) 15 5 16 43
Different classification (%) 7.1 1.2 7.5 10.5
ANM AddNeuroMed cohort model, ANM/ADNI combined AddNeuroMed and
ADNI cohort model, ANMonADNI AddNeuroMed cohort test set and ADNI
training set, ADNIonANM ADNI cohort test set and AddNeuroMed cohort
training set, total n AD and HC subjects, Same classification number of sub-
jects predicted alike, % same classification percentage of subjects predicted
alike, Different classification number of subjects predicted differently, Dif-
ferent classification (%) percentage of subjects predicted differently












HC like (%) **
CA1 65.6 (59) 34.4 (31) 48.2 (172) 51.8 (185)
CA2-3 75.6 (68) 24.4 (22) 52.1 (186) 47.9 (171)
CA4-DG 74.4 (67) 25.6 (23) 51.8 (185) 48.2 (172)
Fimbria 56.7 (51) 43.3 (39) 53.2 (190) 46.8 (167)
Presubiculum 81.1 (73) 18.9 (17) 51.0 (182) 49.0 (175)
Subiculum 77.8 (70) 22.2 (20) 51.3 (183) 48.7 (174)
Combineda 81.1 (73) 18.9 (17) 51.3 (183) 48.7 (174)
Total Hippocampal
volume
76.7 (69) 23.3 (21) 49.9 (178) 50.1 (179)
AD Alzheimer’s disease, MCI mild cognitive impairment, MCIc MCI con-
verter, MCI-s MCI stable, HC healthy control
* Sensitivity at each time point is the percentage of MCIc subjects correctly
classified as AD in bold
** Specificity at each time point is the percentage of MCI-s subjects correctly
classified as HC in bold
a The combined model used the combination of subfields for classification
b Only includes subjects that underwent conversion from MCI to AD at
12 months follow up
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subfields to examine whether subfield volumes could
improve the sensitivity of MRI in detecting AD. The results
suggest that the OPLS technique with fully automated
hippocampal subfield volumes performs as accurately as
total hippocampal volume, presubiculum volume and
subiculum volume in distinguishing between AD and
control subjects. The OPLS method which combined hip-
pocampal subfield measures produced a classification
accuracy of 81.7 % (sensitivity = 80.4 %, specific-
ity = 82.8 %, AUC = 0.895), while total automated hip-
pocampal volume produced an accuracy of 80.7 %
(sensitivity 79.2 %, specificity 82.8 %, AUC = 0.887).
Although significantly different, the magnitude of the dif-
ference is small and does not offer a particular advantage
over hippocampal volume. Recent work has also found that
the visual rating assessment of the medial temporal lobe
produces accuracies that are comparable to that of manual
hippocampal volume in distinguishing between AD and
controls (Westman et al. 2011d).
Although our study is the first to use multivariate ana-
lysis of automated hippocampal subfields, previous
research has examined the combination of automated
regional cortical thicknesses and regional volumes in dis-
tinguishing between AD and control subjects using support
vector machines and linear discriminant analysis (Vemuri
et al. 2008; McEvoy et al. 2009).
Predicting MCI Conversion
Building robust classification models on new and unseen
data is of great importance for accurately predicting future
MCI conversion to AD. MCI predictions were performed
using AD vs. HC models in the combined ADNI and
AddNeuroMed cohorts as classifiers and MCI subjects as
our external validation test set. This approach has been
applied previously and demonstrates how larger training
sets can be used to assess MCI predictions that are more
balanced in terms of sensitivity and specificity (Westman
et al. 2011a). Previous studies in the neuroimaging litera-
ture utilising advanced methods of high dimensional pat-
tern classification (Fan et al. 2008; Misra et al. 2009), and
whole brain structural MRI (Karas et al. 2008; Davatzikos
et al. 2010) have demonstrated the complexity of differ-
ential atrophy patterns observed in MCI-c and MCI-s
subjects. Moreover, studies including our own have also
shown heterogeneous patterns of brain atrophy exist in
MCI subjects that convert to AD and those who remain
clinically stable (Westman et al. 2011c; McEvoy et al.
2009). Consequently, hippocampal subfields were of
interest following a small pilot study in MCI subjects
(Hanseeuw et al. 2011).
Using a large external validation test set (n = 447) we
sought to identify MCI subjects based on the similarity of
their hippocampal subfield pattern to AD patients (% AD-
like) or healthy control subjects (% HC-like). Unlike some
previous studies, the large number of MCI subjects in our
study served to more accurately represent the heterogeneity
of MCI subjects and included both amnestic and non-
amnestic subtypes.
The results demonstrated that the combination of sub-
field volumes and the presubiculum were the most robust
classifiers, identifying 81.1 % of MCI-c correctly, and
Fig. 4 a OPLS scores from the total hippocampal volume classifier for MCI-s predictions, b OPLS scores from the combined subfields volume
classifier for MCI-s predictions
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were better than using total hippocampal volume alone.
However, a considerable number of MCI-s subjects were
also predicted with AD-like patterns of atrophy despite
having a clinically stable MCI condition at 12 months
follow up. Although beyond the scope of the current study
we intend in future to study longitudinal change in hip-
pocampal subfield measures over longer follow up times in
the ADNI cohort. The utility of structural MRI plays a key
role in this domain and represents one of the 3 main bio-
markers for AD diagnosis (Dubois et al. 2007; Frisoni et al.
2010). However, more focus needs to be addressed towards
the standardisation of acquisition and analysis methods in
order to facilitate the integration of findings across studies.
Recently there has been much interest in exploring the
combination of different MRI imaging techniques (i.e.
Tensor based morphometry, cortical thicknesses and vol-
umes) with cerebrospinal fluid (CSF) biomarkers, 18F-
fluorodeoxyglucose PET, and clinical examination for
classifying AD and predicting MCI conversion to AD
(Wolz et al. 2011; Vemuri et al. 2009; Zhang et al. 2011;
Furney et al. 2011). In regards to our study, a longer follow
up time would be helpful to refine our estimates of model
specificity for MCI-s predictions. A more robust algorithm
that could potentially predict future MCI time to AD
conversion would be of future interest to validate our
findings in this present study.
Conclusion
Hippocampal subfield volume loss in AD is widespread
affecting regions such as the CA-1, subiculum, and
presubiculum. Using an automated hippocampal subfield
measurement technique we found prominent subfield vol-
ume losses in MCI converters and AD. Each of the subfield
measures was related to both clinical predictors of AD
(Age, gender, years of education, APOE E4 genotype) and
cognitive scores (MMSE and ADAS-1 tests). Combined
subfield volumes using the OPLS technique produced a
similar classification accuracy to total hippocampal vol-
ume, presubiculum volume and subiculum volume in dis-
tinguishing between AD and HC subjects, but were more
accurate than total hippocampal volume measurements at
predicting MCI conversion to AD at 12 months.
Acknowledgments This study was supported by InnoMed, (Inno-
vative Medicines in Europe) an Integrated Project funded by the
European Union of the Sixth Framework program priority FP6-2004-
LIFESCIHEALTH-5, Life Sciences, Genomics and Biotechnology
for Health. Data collection and sharing for this project was funded by
the ADNI (National Institutes of Health Grant U01 AG024904). Data
collection and sharing for this project was funded by the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) (National Institutes of
Health Grant U01 AG024904) and DOD ADNI (Department of
Defense award number W81XWH-12-2-0012). ADNI is funded by
the National Institute on Aging, the National Institute of Biomedical
Imaging and Bioengineering, and through generous contributions
from the following: Alzheimer’s Association; Alzheimer’s Drug
Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-
Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli
Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated
company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO
Ltd.; Janssen Alzheimer Immunotherapy Research & Development,
LLC.; Johnson & Johnson Pharmaceutical Research & Development
LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics,
LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation;
Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda
Pharmaceutical Company. The Canadian Institutes of Health
Research is providing funds to support ADNI clinical sites in Canada.
Private sector contributions are facilitated by the Foundation for the
National Institutes of Health (www.fnih.org). The grantee organiza-
tion is the Northern California Institute for Research and Education,
and the study is coordinated by the Alzheimer’s Disease Cooperative
Study at the University of California, San Diego. ADNI data are
disseminated by the Laboratory for Neuro Imaging at the University
of California, Los Angeles. Also, thanks to the Foundation Gamla
Tja¨narinnor, the Swedish Alzheimer’s Association and Swedish Brain
Power, Health Research Council of Academy of Finland and Stock-
holm Medical Image Laboratory and Education (SMILE). AS, EW,
J-SM and SL were supported by funds from NIHR Biomedical
Research Centre for Mental Health at the South London and
Maudsley NHS Foundation Trust and Institute of Psychiatry, King’s
College London.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
Apostolova LG et al (2006) Conversion of mild cognitive impairment
to Alzheimer disease predicted by hippocampal atrophy maps.
Arch Neurol 63(5):693–699
Apostolova LG et al (2010) 3D comparison of low, intermediate, and
advanced hippocampal atrophy in MCI. Hum Brain Mapp
31(5):786–797
Barnes LL et al (2005) Sex differences in the clinical manifestations of
Alzheimer disease pathology. Arch Gen Psychiatry 62(6):685–691
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-
related changes. Acta Neuropathol 82(4):239–259
Bylesjo M et al (2006) OPLS discriminant analysis : combining the
strengths of PLS-DA and SIMCA classification y. J Chemom
20:341–351
Costafreda SG et al (2011) Automated hippocampal shape analysis
predicts the onset of dementia in mild cognitive impairment.
Neuroimage 56(1):212–219
Csernansky JG et al (2005) Preclinical detection of Alzheimer’s
disease: hippocampal shape and volume predict dementia onset
in the elderly. Neuroimage 25(3):783–792
Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis.
I. Segmentation and surface reconstruction. Neuroimage
9(2):179–194
Davatzikos C et al (2010) Prediction of MCI to AD conversion, via
MRI, CSF biomarkers, and pattern classification. Neurobiol
Aging 32(12):2322e19–2322e27
Desikan RS et al (2009) Automated MRI measures identify individ-
uals with mild cognitive impairment and Alzheimer’s disease.
Brain 132(8):2048–2057
Brain Topogr (2015) 28:746–759 757
123
Devanand DP et al (2007) Hippocampal and entorhinal atrophy in
mild cognitive impairment: prediction of Alzheimer disease.
Neurology 68(11):828–836
Dubois B et al (2007) Research criteria for the diagnosis of
Alzheimer’s disease: revising the NINCDS-ADRDA criteria.
Lancet Neurol 6(8):734–746
Fan Y et al (2008) Spatial patterns of brain atrophy in MCI patients,
identified via high-dimensional pattern classification, predict
subsequent cognitive decline. Neuroimage 39(4):1731–1743
Fischl B et al (2002) Whole brain segmentation: automated labeling
of neuroanatomical structures in the human brain. Neuron
33(3):341–355
Fischl B et al (2004) Sequence-independent segmentation of magnetic
resonance images. Neuroimage 23(Suppl 1):S69–S84
Fox NC et al (1996) Presymptomatic hippocampal atrophy in
Alzheimer’s disease. A longitudinal MRI study. Brain 119(Pt
6):2001–2007
Frisoni GB et al (2010) The clinical use of structural MRI in
Alzheimer disease. Nat Rev Neurol 6(2):67–77
Furney, SJ et al (2011) Combinatorial markers of mild cognitive
impairment conversion to Alzheimer’s disease–cytokines and
MRI measures together predict disease progression. J Alzheimers
Dis 26(Suppl 3(3)):395–405
Gouras GK et al (2000) Testosterone reduces neuronal secretion of
Alzheimer’s b-amyloid peptides. Proc Natl Acad Sci USA
97(3):1202–1205
Hanseeuw BJ et al (2011) Mild cognitive impairment: differential
atrophy in the hippocampal subfields. AJNR Am J Neuroradiol
32(9):1658–1661
Jack CR et al (1992) MR-based hippocampal volumetry in the
diagnosis of Alzheimer’s disease. Neurology 42(1):183–188
Jack CR et al (1998) Hippocampal atrophy and apolipoprotein E
genotype are independently associated with Alzheimer’s disease.
Ann Neurol 43(3):303–310
Jack CR et al (2008) The Alzheimer’s disease neuroimaging initiative
(ADNI): MRI methods. J Magn Reson Imaging 27(4):685–691
Karas G et al (2008) Amnestic mild cognitive impairment: structural
MR imaging findings predictive of conversion to Alzheimer
disease. AJNR Am J Neuroradiol 29(5):944–949
Klo¨ppel S et al (2008) Automatic classification of MR scans in
Alzheimer’s disease. Brain 131(Pt 3):681–689
Lerch JP et al (2008) Automated cortical thickness measurements
from MRI can accurately separate Alzheimer’s patients from
normal elderly controls. Neurobiol Aging 29(1):23–30
Liu Y et al (2009) Combination analysis of neuropsychological tests and
structural MRI measures in differentiating AD, MCI and control
groups-The AddNeuroMed study. Neurobiol Aging 32(7):1198–1206
Lovestone S et al (2009) AddNeuroMed–the European collaboration
for the discovery of novel biomarkers for Alzheimer’s disease.
Ann N Y Acad Sci 1180:36–46
Mangialasche F et al (2010) High plasma levels of vitamin E forms
and reduced Alzheimer’s disease risk in advanced age. J Alzhei-
mers Dis 20(4):1029–1037
McEvoy LK et al (2009) Alzheimer disease: quantitative structural
neuroimaging for detection and prediction of clinical and
structural changes in mild cognitive impairment. Radiology
251(1):195–205
Misra C, Fan Y, Davatzikos C (2009) Baseline and longitudinal
patterns of brain atrophy in MCI patients, and their use in
prediction of short-term conversion to AD: results from ADNI.
Neuroimage 44(4):1415–1422
Mueller SG, Weiner MW (2009) Selective effect of age, Apo e4, and
Alzheimer’s disease on hippocampal subfields. Hippocampus
19(6):558–564
Mueller SG et al (2010) Hippocampal atrophy patterns in mild
cognitive impairment and Alzheimer’s disease. Hum Brain
Mapp 31(9):1339–1347
Plant C et al (2010) Automated detection of brain atrophy patterns
based on MRI for the prediction of Alzheimer’s disease.
Neuroimage 50(1):162–174
Reiman EM et al (1998) Hippocampal volumes in cognitively normal
persons at genetic risk for Alzheimer’s disease. Ann Neurol
44(2):288–291
Robin X et al (2011) pROC: an open-source package for R and
S ? to analyze and compare ROC curves. Bioinformatics
12(1):77
Scheltens P et al (1992) Atrophy of medial temporal lobes on MRI in
‘‘probable’’ Alzheimer’s disease and normal ageing: diagnostic
value and neuropsychological correlates. J Neurol Neurosurg
Psychiatry 55(10):967–972
Se´gonne F et al (2004) A hybrid approach to the skull stripping
problem in MRI. Neuroimage 22(3):1060–1075
Simmons A et al (2009) MRI measures of Alzheimer’s disease and
the AddNeuroMed study. Ann N Y Acad Sci 1180:47–55
Simmons A et al (2011) The AddNeuroMed framework for multi-
centre MRI assessment of Alzheimer’s disease: experience from
the first 24 months. Int J Geriatr Psychiatry 26(1):75–82
Spulber G et al (2013) An MRI-based index to measure the severity of
Alzheimer’s disease-like structural pattern in subjects with mild
cognitive impairment. J Intern Med 273(4):396–409
Trygg J, Wold S (2002) Orthogonal projections to latent structures
(O-PLS). J Chemom 16(3):119–128
Van Leemput K et al (2009) Automated segmentation of hippocampal
subfields from ultra-high resolution in vivo MRI. Hippocampus
19(6):549–557
Vemuri P et al (2008) Alzheimer’s disease diagnosis in individual
subjects using structural MR images: validation studies. Neuro-
image 39(3):1186–1197
Vemuri P et al (2009) MRI and CSF biomarkers in normal, MCI, and
AD subjects: predicting future clinical change. Neurology
73(4):294–301
West MJ et al (2004) Hippocampal neurons in pre-clinical Alzhei-
mer’s disease. Neurobiol Aging 25(9):1205–1212
Westman E, Wahlund LO, Foy C et al (2010) Combining MRI and
MRS to distinguish between Alzheimer’s disease and healthy
controls. J Alzheimers Dis 22(1):171–181
Westman E, Simmons A, Muehlboeck J-S et al (2011a) AddNeur-
oMed and ADNI: similar patterns of Alzheimer’s atrophy and
automated MRI classification accuracy in Europe and North
America. Neuroimage 58(3):818–828
Westman E, Wahlund L, Foy C et al (2011b) Magnetic
Resonance Imaging and Magnetic Resonance Spectroscopy
for Detection of Early Alzheimer’ s Disease. J Alzheimers
Dis 26:307–319
Westman E, Simmons A, Zhang Y et al (2011c) Multivariate analysis
of MRI data for Alzheimer’s disease, mild cognitive impairment
and healthy controls. Neuroimage 54(2):1178–1187
Westman E, Cavallin L, Muehlboeck J-S et al (2011d) Sensitivity and
Specificity of Medial Temporal Lobe Visual Ratings and
Multivariate Regional MRI Classification in Alzheimer’s Dis-
ease J. Laks, ed. PLoS One 6(7):9
Westman E, Muehlboeck J-S, Simmons A (2012) Combining MRI
and CSF measures for classification of Alzheimer’s disease and
prediction of mild cognitive impairment conversion. Neuroim-
age 62(1):229–238
Westman E et al (2013) Regional magnetic resonance imaging
measures for multivariate analysis in Alzheimer’s disease and
mild cognitive impairment. Brain Topogr 26(1):9–23
758 Brain Topogr (2015) 28:746–759
123
Wiklund S et al (2008) Visualization of GC/TOF-MS-based metabolo-
mics data for identification of biochemically interesting com-
pounds using OPLS class models. Anal Chem 80(1):115–122
Wolz R et al (2011) Multi-method analysis of MRI images in early
diagnostics of Alzheimer’s disease. PLoS One 6(10):e25446
Zhang D et al (2011) Multimodal classification of Alzheimer’s
disease and mild cognitive impairment. Neuroimage 55(3):
856–867
Brain Topogr (2015) 28:746–759 759
123
